Xavier Guillory, Elodie Lafont e Mathéo Lodé do Proteostasis and Cancer Team INSERM U1242 revisaram Engineering ERα degraders with pleiotropic ubiquitin ligase ligands maximizes therapeutic efficacy by co-opting distinct effector ligases Biologia Molecular Avaliação publicada 8 de novembro de 2024 Servidor de preprints bioRxiv